Dr Testorri speaks with ecancer at EADO 2017 about preserving patient quality of life with loco-regional control of disease.
He highlights the considerations of how best relieve patients of disease burden without unnecessary damage to healthy tissue, especially when lesions and scars would be highly visible.
Dr Testorri reports successes with combining immune therapies with surgical interventions, and describes how electrochemotherapy can improve cytotoxic uptake into cancer cells.
ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.